Nautilus Biotechnology

Performance

About Nautilus Biotechnology

Nautilus Biotechnology is a biotechnology company developing a high-resolution proteomics platform that uses Iterative Mapping to quantify proteins and proteoforms. The platform aims to provide broad and deep views of the proteome to enable applications in drug development, biomarker discovery, and basic biology across biomedical research. The company emphasizes making proteomics insights accessible to researchers, with operations and research focused in the United States and on a global research community. Nautilus positions itself as advancing proteomics capabilities to accelerate discoveries in biology, disease, and therapeutics.